Home / Transcripts / Innovative Industrial Properties, Inc. (IIPR) · February 24, 2026

Innovative Industrial Properties, Inc. (IIPR) Earnings Call Transcript

February 24, 2026

New York Stock Exchange US Real Estate Industrial REITs earnings 38 min

Earnings Call Speaker Segments

Eli Kanter executive
#1

We appreciate everyone being on the line today. With us to present are Alan Gold, who serves as Executive Chairman; Paul Smithers, our President and Chief Executive Officer; David Smith, the Chief Financial Officer; and Ben Regin, Chief Investment Officer. Prior to getting started, I want to remind all of you that certain statements shared on this conference call today, which include ones concerning possible transactions under letters of intent, constitute forward-looking statements as defined by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and they carry risks and uncertainties. Outcomes could vary materially, so we point you toward our SEC filings, in particular our latest report on Form 10-K, where you'll find a thorough discussion of the risk factors that might lead actual results to diverge materially from what those forward-looking statements suggest. We have no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless the law requires it. Additionally, during this call we'll be talking about some non-GAAP financial information, including FFO, normalized FFO and AFFO. That information, along with reconciliations to the most directly comparable GAAP financial measure, is available in our earnings release that went out yesterday and in our 8-K filed with the SEC. At this point I'll turn things over to Alan?

Alan Gold executive
#2

Thanks, Eli, and good morning. We appreciate everyone being on the call today. The year 2025 stood out as one marked by disciplined execution, a strong balance sheet, and strategic repositioning aimed at long-term growth; across the entire year, our diversified platform — spanning more than $2.5 billion in gross assets — produced roughly $200 million in cash flows from operations. On top of that, going back to when we started in 2016, we've delivered $1.1 billion back to shareholders via dividends, which speaks to how durable our business model is and how committed we remain to sharing our cash flows with shareholders. In 2025, we put capital to work in a careful way that added value: $275 million went into our real estate holdings and our strategic investment in IQHQ, making our platform both stronger and more varied. Operationally, we moved the portfolio forward in a meaningful way. During the year, we executed new leases at 4 properties covering roughly 339,000 square feet, and that gives us greater confidence in how good our assets are and in our team's capacity to produce results across the portfolio. Total revenues for the year were $266 million, while AFFO was $205 million. We strengthened our liquidity as well over the course of the year. In October, we brought in $100 million through a new revolving credit facility, and we issued roughly $25 million in preferred stock via our ATM. Turning to 2026, we plan to continue tapping the capital markets when opportunities arise. Already, we have raised more than $40 million in preferred stock, carrying an appealing yield slightly above 9.5% — a figure that surpasses everything we raised throughout 2025. We closed out the year with total liquidity exceeding $105 million, which includes cash along with the availability under our credit facilities. As we broaden our platform, our confidence stays strong in the long-term fundamentals that support the life science sector. Talks we had at the JPMorgan Healthcare Conference last month keep strengthening our belief that this sector is starting to show the first hints of a pickup. We're seeing improved access to capital for life science companies with solid balance sheets, growing strategic deal-making among the big pharma players, and innovation that hasn't slowed down. All of that is fueling steady need for purpose-built properties in the top life science markets. Before turning things over to Paul, I want to spend a moment on a recent regulatory shift affecting cannabis. The executive order from President Trump that moves cannabis toward Schedule III is a major regulatory milestone for that industry. Even though we can't say for sure when or exactly how this will play out, we see it as a step in the right direction for the sector, for the people who rent from us, and for those who own our stock. What we did during 2025 marks a significant move forward in how our company has developed and in getting back to expanding. We think that having a mix of assets spanning both cannabis and life science, paired with a solid financial position and a leadership group with plenty of experience, puts us in a position to keep making our platform stronger and to produce lasting worth for our investors. With that said, I'll now hand things over to Paul.

Paul Smithers executive
#3

Thank you, Alan. Let me start by underscoring how important the executive board's recent move to have cannabis rescheduled to Schedule III really is. Though we still don't know the exact timeline or how it will ultimately be carried out, this ranks among the most significant regulatory shifts the industry has seen in a long time. Should it take effect, rescheduling could remove the punitive burden of 280E for the people leasing from us, which we expect would deliver a meaningful boost to operator cash flows, make credit profiles stronger and encourage further investment throughout the industry; on top of that, the Executive Board pointed to worries about the spread of THC products derived from hemp. New legislation that shuts down certain loopholes in the 2018 Farm Bill should curb hemp-derived THC products starting in November 2026, which ought to cut down on unregulated goods and bolster consumer safety throughout the U.S. When it comes to the states, we're monitoring a number of notable catalysts ahead, such as the possible launch of adult-use sales in Virginia along with the potential legalization of adult use in Pennsylvania and Florida; across those states we hold 16 properties spanning roughly 2.6 million square feet, representing about 26% of annualized base rent, and we feel our real estate and the tenants we have are positioned well to gain as those markets make the shift to adult use. Turning to the portfolio we have now, as you'll remember, back in March we rolled out initiatives aimed at swapping out underperforming tenants and lifting how our portfolio performs. Since that time, receivership and legal proceedings have carried on involving Forefront Ventures, PharmaCann and Gold Flora, and we've kept pressing our legal rights and safeguarding our stake under those leases; we've stayed actively involved across these assets and are happy with how much progress has been achieved. We've executed leases, signed LOIs and are at various points of review for more than 900,000 square feet of leasing activity tied to those assets, and Ben will get into that in greater depth. We think we've reached an inflection point in our push to resolve the assets in the portfolio that previously weren't performing, and we expect coming quarters to show the earnings upside those steps will unlock. Our team's execution and its record of retenanting our assets fast and effectively, getting the most out of our portfolio and generating long-term value for our shareholders, makes us incredibly proud. Finally, we're glad to pass along a legal update as well. Last month, a judgment came down in our favor worth $7 million covering unpaid rent and damages owed by Temescal Wellness, a former tenant at one of our Massachusetts properties. I'd now like to hand the call to Ben so he can give more specifics on our leasing success and talk through our other investment activities. Ben?

Ben Regin executive
#4

Appreciate that, Paul. Looking back at 2025 as a whole, we signed new leases amounting to 339,000 square feet at properties in California, Massachusetts and Michigan, took advantage of chances to complete 3 dispositions, and finalized roughly $275 million of fresh investment activity, which included a single cannabis acquisition along with our strategic investment in IQHQ — we've put $150 million into that one so far. That momentum has carried us into 2026. Like Paul said, we're quite happy with what we're seeing around the Gold Flora and Forefront receiverships, plus our legal efforts involving PharmaCann. Gold Flora entered voluntary receivership in March of 2025, and since then we've achieved solid progress in getting our 3 properties back. During the fourth quarter we signed a lease with a new tenant for our Palm Springs asset of 70,000 square feet, last month we signed a lease with a new tenant for our Desert Hot Springs asset of 204,000 square feet, and for a 56,000 square foot Palm Springs asset we've gotten several offers. All in all, the receivership results and the resolution we reached on these properties leave us quite pleased. When it comes to our 4 assets that Forefront previously leased, our re-tenanting efforts on them have advanced considerably. This quarter we came to a tentative deal with the tenant to lease our 114,000 square foot Washington property, and we anticipate the lease being executed and rent starting soon. For our 250,000 square foot asset in Illinois, we've signed an LOI covering the entire building with a new operator, which should take effect when the receivership proceedings close, expected over the next few quarters. For a 67,000 square-foot property in Georgetown, Massachusetts, the receivership has chosen a stalking horse bidder, and we've settled on lease terms with that bidder. We anticipate this new lease taking effect once the receivership process wraps up. As for our 57,000 square foot property in Holliston, Massachusetts, multiple offers to lease the building have come in and are being reviewed right now. We're eager to keep pushing these transactions ahead and get these properties resolved. Turning to the properties leased to PharmaCann, we remain pleased with how far we've come in re-tenanting our 6 cultivation assets. Early in 2025 we took back possession of our 205,000 square foot cultivation asset in Michigan and then signed a lease with a new tenant in April. We also managed to regain possession of our 58,000 square foot cultivation asset in Massachusetts and signed a lease with a new tenant in November. In Illinois, as we told you last quarter, the judge's ruling went our way regarding our 66,000 square foot cultivation property, and in late December we successfully got possession back, then signed an LOI with a new tenant for it in January. As we look forward, we anticipate comparable court decisions coming in Pennsylvania, Ohio and New York, and the early interest we've gotten on those assets gives us encouragement. Beyond those properties, we're happy to share that in February we executed an LOI with a new tenant covering a 71,000 square foot space that sits vacant in North Adams, Massachusetts. Alongside our leasing efforts, we've been pursuing chosen asset dispositions as a way to recycle capital when attractive chances arise. Over the course of 2025, we disposed of 3 assets in California, Colorado and Michigan, and earlier this month we completed the sale of a dispensary in Phoenix; taken together, these sales show our continuing push to opportunistically trim noncore holdings, lift the quality of the portfolio overall and put capital back to work in other investments. On our strategic investment in IQHQ, we have funded $150 million so far out of a $270 million commitment, with the remaining $120 million anticipated to be funded over time. This investment gives us encouragement, and we think the life science real estate market keeps stabilizing after an extended stretch of heavy supply. Today's construction pipeline of roughly 6 million square feet stands at the lowest level it has seen since early 2019 and has fallen dramatically from the 2023 peak of more than 37 million square feet. Evidence of stabilization is starting to show up in key markets. Newer reports out of Cushman & Wakefield and Colliers point to better fundamentals in certain regions. In Boston, annual new demand reached 2.1 million square feet, exceeding 2024 totals by about 72%. The San Francisco Peninsula saw its first vacancy decrease in over 2 years during Q4 2025. We expect continued expansion among life science and AI tenants to drive lasting improvement in market conditions in 2026 as supply eases and demand steadily picks up; with that, I'll hand the call to David.

David Smith executive
#5

Thanks, Ben. In Q4, our total revenues came in at $66.7 million, while AFFO was $53.3 million, equal to $1.88 per share — that's a 10% gain over the $1.71 per share of AFFO we posted in the third quarter of 2025. Two things mainly drove this sequential increase: $3.7 million, or $0.13 per share, of payments we collected for rent that went unpaid while Gold Flora was in receivership, plus a full quarter of earnings accretion benefit from the initial investment we made in IQHQ. Turning to the first quarter of 2026, as Ben walked through, we're still working to recover unpaid rents tied to certain tenants in default, and to date we've brought in another $3 million, or $0.10 per share, tied to our Gold Flora and PharmaCann properties. On the capital markets side, since October 2025 we've raised more than $145 million of debt and preferred equity at attractive pricing. Where preferred stock is concerned, in the fourth quarter of 2025 we issued roughly $5 million through our ATM, and early in the first quarter of 2026 we've already issued more than $40 million of preferred equity at an appealing yield of slightly above 9.5%, which shows investor demand for this perpetual security remains strong. Through our ATM issuances, we've now built our Series A preferred stock up to $95 million of par value outstanding. On the debt side, in the fourth quarter we brought in a new $100 million revolving credit facility secured by our IQHQ investment, giving us low-cost, flexible capital at an appealing 6.1% rate and further strengthening our liquidity profile. Back in August when we announced the IQHQ transaction, one benefit we anticipated was the chance to tap lower-cost capital, and we're glad to see that materialize with this new credit facility closing. This ongoing access to capital bolsters our capacity to fund growth opportunities while keeping our balance sheet conservative. Our balance sheet is still strong, backed by more than $2 billion of unencumbered real estate and a conservative capital structure, with a debt service coverage ratio above 10x and net debt to adjusted EBITDA of 1.4x; we closed the quarter with more than $107 million in total liquidity, counting cash on hand and availability under our revolving credit facilities, which the year-to-date preferred stock ATM issuances I mentioned earlier improved even further. Regarding our bond maturity at the end of May, we're actively weighing a range of alternatives to handle that obligation, including possible refinancing and other capital sources. We believe our unencumbered asset base, over $2 million of real estate, along with our strong credit profile, puts us in a good position as we explore those alternatives. With that, thanks for joining the call, and we'd like to open it up for questions. Operator, could you please open the call for questions?

William Catherwood analyst
#6

It's good to see the progress on leasing during Q4, and clearly, in 2026 so far; regarding that improvement, are cannabis operators wanting to grow once more? Or do they want to shift toward higher quality through new facilities? Or did your approach to leasing change during the last quarter? Or is another factor behind this pickup in activity?

Alan Gold executive
#7

Okay, well, to begin with, I appreciate the question. There are, I believe, many things happening here. First, our management team is highly seasoned and has been engaged with this sector for 8 plus nearly 10 years. And they are carrying out the business plan that we — that we laid out in — at the close of 2024 and across 2025, and keep going, and we expect to keep carrying out that business plan across 2026. This shift back toward growth stems from, as we mentioned in prior quarters, the fact that we were noticing a few green shoots within the industry. And those green shoots have enabled, in our view, the operators in our — the stronger operators in our sector to benefit from some of the weaker operators who have not managed to steer through these tough periods in the industry as effectively. Yet we continue to think there are major difficulties in the cannabis sector, even though we do observe distinctive possibilities and, by collaborating with some of the finest cultivators in our portfolio and in the nation, we think there are distinctive possibilities to capitalize on that — on those. Ben, do you have anything or Paul, is there anything else you'd like to add?

Ben Regin executive
#8

Ben here. Yeah, let me just add on — I'd say operators definitely view the rescheduling development as a good thing. A bunch of our biggest tenants have managed to pull off refinancings or bring in new debt over the past few <<inaudible>>, and Cresco is one of them. On top of that, they look at these chances to expand as a fairly cheap route into what we consider top-tier turnkey properties, and we're genuinely thrilled about how well the team can turn that appetite into the leasing momentum we've been discussing.

William Catherwood analyst
#9

Thanks for taking those questions. Ben, as a quick follow-up on that point: sometimes what you read in the headlines doesn't match what's really going on. Take U.S. cannabis — the coverage talks about too much supply in Massachusetts, Michigan, and California. Yet you've managed to re-lease properties successfully in those places, and you've done well in tougher markets too, like the leases and LOIs you closed recently in Illinois. Does your strategy look any different across those 2 markets? Or would you say the headlines exaggerate how hard it is to re-lease in states where competition is fiercer?

Ben Regin executive
#10

My view is that headlines give you only a broad, surface-level picture of certain markets. When you dig deeper — and we draw on what we've learned across the last decade to grasp what makes each market distinct — you locate the operators who are thriving and efficient in places such as California, Massachusetts, and Michigan, you figure out which teams we have confidence in, the ones we believe can expand their operations profitably, and you add them to our portfolio. That, in our view, is very sensible. It's the identical playbook we'd apply anywhere.

William Catherwood analyst
#11

Understood. Thanks for that, Ben. For my final question, I just want some clarity regarding the tenants currently in default. From what I'm hearing, it seems the results tend to fall into 3 categories. One possibility is that the receivership is proceeding and payments will restart once that process wraps up — or, in the second category, you take the space back and, clearly, re-lease it? Then there's a third category where certain tenants kept paying, even though you may not be recognizing that rent, and you keep working to recover their facilities. Among those, which ones could see rent resume soon, when the receivership ends, and which ones land in the re-leasing group, and which are still battling to get properties back?

Alan Gold executive
#12

Well — I'll hand these questions to Paul and Dan. Though, to clarify one thing, when rent comes in, we book it as revenue. That's not — that's exactly what we've been doing; so regarding that third category of — some tenants are in default and the court has directed them to pay rent or deposit it into escrow and that — once those funds are freed up, we record that rent; so let's just — that's the clarification I wanted to make. With that said, Paul.

Paul Smithers executive
#13

This is Paul. Let me break that down a bit further. Really, I'd point to 2 categories. We examine tenants who have defaulted and are now in receivership, along with those currently involved in litigation. So we went into detail regarding the receivership situation, Gold Flora and Forefront. I believe we've achieved some strong outcomes getting those resolved. And recognizing that with receivership, there are usually administrative costs, which represent deferred rent we aren't collecting right now, and typically we receive that once the receivership concludes. The second category is mainly ParmaCann, where we're in the later phases of the litigation process on those cases. And we expect to reach resolutions on those before long; so we view it in a simpler way, those in receivership and those that aren't. Either way, we're quite happy with where things stand now versus where they stood 12 months ago. And I think Ben and his team have done a fantastic job re-leasing those assets where, a year ago, there was some doubt. I'm aware people were saying, gee, these are challenging markets. Will we struggle to get these leases entered into, but we showed those people they were mistaken and did a fine job re-leasing those.

Analyst analyst
#14

John here, filling in for Aaron. About those LOIs you've signed or the new term agreements reached for the 4Front assets — could you give us some insight into what the new rental rates look like and how they compare with what the respective tenant was paying before default? Naturally, it likely differs property to property and state to state. Still, any information on a broad haircut that may have been required would be useful.

Ben Regin executive
#15

John, it's Ben here. A few points come to mind. Clearly, with a number of these deals — these and others — negotiations are ongoing, and for competitive reasons, we won't reveal the precise figures on a deal-by-deal basis. Broadly, though, we've observed a range of outcomes. In some unique situations, certain assets historically could sit around 50%, under 50% of contract, while in other cases you're essentially right at the prior lease rates. It's quite a wide range, depending on each individual situation.

Alan Gold executive
#16

I'd also mention that we've encountered a number of quite encouraging cases in which capital expenditures tied to re-leasing came in far below what anyone had expected. Would you agree?

Ben Regin executive
#17

Yeah, I'd say you've got that exactly right. And one important point to remember is that for this re-leasing work, we're usually at $15 per square foot or less. Many of the tenants who've moved into our properties have actually put in their own capital to fund further upgrades to our buildings. So those rental rates arrive with only a small capital outlay from us, which has been wonderful to watch.

Alan Gold executive
#18

And all those factors go into the rental rate that is finally negotiated.

Analyst analyst
#19

Okay. Great. And then secondly, when it comes to the dividend and how earnings cover it moving forward: on one hand, you received additional one-time payments from tenants who had defaulted, especially during 4Q, which helped and closed the gap in the dividend; you also have IQHQ interest income, and that ought to keep growing together with new lease tenants coming from those who previously defaulted. So, on a normalized basis, do you believe you're better positioned to have the dividend completely covered soon, or are gradual measures such as getting more properties re-leased required?

Alan Gold executive
#20

Well, I think, first of all, regarding the dividend — our Board determines our dividend policy, and they look at what has happened previously. And projections moving forward. But what we're observing is this return to growth, and we're observing very very strong re-leasing activity that is pushing revenues; and we keep seeing — and we have the resolutions of certain of these major lease litigations. And with those resolutions, and the activity, the leasing activity we're observing, we consistently feel good about where we stand when it comes to our dividend.

Bill Kirk analyst
#21

So after that executive order, what's been observed regarding how healthy tenants are and, perhaps even more crucially, their readiness to pay on schedule. I realize we've already touched briefly on the removal of 280E and the way that boosts health down the road; but what about right now, ahead of the rescheduling shift? What are you noticing when it comes to tenant willingness and tenant health?

Alan Gold executive
#22

Well, I'd say our tenants — as we've reported — are paying their rents. So — and they're paying them on time and per the leases. But I'll turn that back — I'll turn the question over to Paul to talk about the rescheduling and how it's benefited the industry.

Paul Smithers executive
#23

Right, Bill, I believe you're tracking this pretty well. Two months back, when the President made that executive order announcement, it mattered a great deal. It's generated quite a bit of chatter, I'd say, along with some upbeat sentiment across the industry — particularly among our bigger MSOs, the ones eager to expand and hunting for leases in additional states, which our re-leasing figures make clear. So people are wondering about the timing and the mechanics of how the EO gets put into place, yet it will be carried out. That, I'd say, captures how the industry feels at this point. So even though there's ambiguity around the timing — we're seeing a clear, favorable energy that stems purely from the executive order being announced.

Alan Gold executive
#24

That's among the positive signals we've noticed. Still, the border closure and the stricter wholesale pricing in certain markets — I believe all of that contributes to making our tenants' financial health better.

Bill Kirk analyst
#25

Also, I suppose there's a potential — or perhaps impending — prohibition on intoxicating hemp in the U.S. around the middle of November. A lot of those intoxicating hemp items are rivals to your tenants. Does that factor into your better re-leasing forecast, or into how tenants perceive their own future, knowing an intoxicating hemp rival might disappear during this year?

Alan Gold executive
#26

That's a fascinating point. And my view is we'll simply need to wait and observe. In our opinion, the market's firming up stems from multiple factors. And each of these modest, step-by-step gains benefits every one of our tenants.

Alexander Goldfarb analyst
#27

Just a handful of items. To start, I appreciate that you added the new table covering the problematic tenants and the amounts they've remitted across time. Ideally, that could be broadened to cover leases that are fully settled as opposed to those still being negotiated — it would simply assist with all of the conversation. So, a handful of items here. First, turning to the opportunity set, you have that intriguing table chart displaying the scale of the cannabis sector, the legal cannabis sector against the different alcohol sectors. And cannabis is fairly large, particularly if you were to even factor in the black market. But given how substantial it is, you folks speak more about moving toward life science; so is it — as we consider the company across the coming years, even as additional states consider legalization and maybe cannabis gets reclassified to Schedule III. Do you believe that life science delivers a superior risk-adjusted return over the next several years even if cannabis manages to fix its present problems and return to being more of a growth arena?

Alan Gold executive
#28

Well, I believe that the diversification away from the — into the life science sector is multifaceted as well; and it isn't solely that — I mean it isn't solely regarding the distinct opportunity that we see — that we saw within the life science sector, how that sector had possibly reached its lowest point and that there were signs of recovery and growing opportunities and a means to employ our cost of capital or capitalize on opportunities using our cost of capital. ; so I think that's one of the reasons for diversification. But there's also the reality that through diversifying, we might unlock broader sources of capital and provide ourselves the chance to lower our overall cost of capital through that diversification. And I think we are carrying that out and witnessing some of the advantages of it as we continue.

Alexander Goldfarb analyst
#29

And moving on to that same topic with HQ, I believe the last time you gave us an update on the leasing, or the leasing situation, the portfolio stood at approximately 25% leased. Do you have anything new? Has there been any movement, or does it remain roughly where it was?

Alan Gold executive
#30

Since they're a private organization, nothing has been made public by them as of yet. That said, across the markets broadly, we're noticing a meaningful pickup in leasing activity, particularly in the Boston markets — Boston, and then the Bay Area. And historically, whenever the industry bounces back, whenever the life science real estate sector bounces back, the Boston area is where it comes back first, followed by the Bay Area, and after that it spreads to San Diego. And we're — and we're watching that play out right now.

Alexander Goldfarb analyst
#31

All right. Then my last item here: I saw in the revised K regarding litigation that the SEC has now gotten involved, yet you folks carry no legal reserve. Could you share what we ought to anticipate for legal expenses during this year? My sense is it has come to roughly $2 million on average across the last few years. And clearly that figure covers everything; it spans many matters, including your pursuit of multiple tenants who have been making payments. But could you simply provide some sense of what to expect on legal costs? Also, what leads a company to establish a legal reserve, as opposed to your current situation where none exists?

David Smith executive
#32

Yes, Alex, this is David. Regarding that legal reserve, we have not recorded one. Nor have our auditors mandated it, as the 10-K disclosed. So we will be sorting through this. Costs are going to come, though pinning down an estimate right now is difficult.

Paul Smithers executive
#33

Let me jump in here. Paul, Alex, a great deal of those legal expenses stemmed from tenants failing to pay and from what we've done to remove them from the buildings, plus everything tied to the receivership. So the costs involved are substantial. Our expectation is that these matters get settled over the coming 2 quarters. That means we should see some reduction on the legal spend.

Alexander Goldfarb analyst
#34

But what's behind setting up a reserve? What makes auditors decide that a company — speaking generally, any company — needs to put a reserve in place rather than none at all?

David Smith executive
#35

Right. I'd simply refer you to what the 10-K states, that it's neither probable nor unlikely. And unless it turns into one of those two — probable — that might call for something.

Alan Gold executive
#36

Thanks. And above all, I want to — I have to give credit to the team for how well they've delivered and the solid effort that brought us to this point, and for how ready we think we are for chances ahead as things change over time. We'd also like to express our appreciation for the backing of our stakeholders. And on that note, we'll bring the call to a close. Thanks.

Operator operator
#37

This concludes today's conference call. Thank you for joining. You may now disconnect.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Innovative Industrial Properties, Inc. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to Innovative Industrial Properties, Inc. earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.